Palvella Therapeutics, Inc. (PVLA)
98.58
+1.80
(+1.86%)
USD |
NASDAQ |
Dec 12, 16:00
98.68
+0.10
(+0.10%)
After-Hours: 20:00
Palvella Therapeutics Total Liabilities (Quarterly): 28.26M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 514.76M |
| Ligand Pharmaceuticals, Inc. | 526.60M |
| Pelthos Therapeutics, Inc. | 68.18M |
| Inhibrx Biosciences, Inc. | 140.64M |
| CEL-SCI Corp. | 13.31M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 66.94M |
| Shareholders Equity (Quarterly) | 38.68M |
| Debt to Equity Ratio | 0.4142 |
| Current Ratio | 6.491 |
| Net Debt Paydown Yield | -0.46% |